Cancer NetworkOriginal article
<![CDATA[Stratifying By Baseline Tumor Cell Density Indicates Treatment Effect Heterogeneity in Rectal Cancer]]>
Data ReadoutpositivePositive
AI Analysis
Summary
A post-hoc analysis of the ARISTOTLE trial demonstrated that rectal cancer patients with high baseline tumor cell density experienced improved disease-free and overall survival, suggesting treatment effect heterogeneity based on tumor cell density stratification.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Post-hoc analysis of ARISTOTLE trial showed patients with high tumor cell density had improved disease-free survival (DFS) and overall survival (OS)
Importance:5/10
Sentiment:
0.60
rectal cancerpost-hoc analysisARISTOTLE trialtumor cell densityDFSOStreatment stratification
Read the original article
Published by Cancer Network on August 13, 2026 7:00 PM